Dr. John D. Allendorf is the chief of surgical oncology at NYU Winthrop Hospital in Mineola, New York. Dr. Allendorf is board-certified by the American Board of Surgery and has more than 20 years of experience, also serving as the vice chairman of the Department of Surgery, chief of surgical oncology and the director of the Hepatobiliary and Pancreatic Surgery Program at NYU Winthrop Hospital.
Dr. Allendorf has worked alongside Dr. John A. Chabot in treating patients diagnosed with mesothelioma, specifically peritoneal mesothelioma. Dr. Allendorf has taken part in mesothelioma research with the Columbia University Mesothelioma Center. In addition to mesothelioma, he also treats adrenal tumors, pancreatic cancer, thyroid cancer, gastrointestinal cancer, goiter and other diseases of the liver, pancreas and endocrine system.
Main Specialty: Surgery
Other Interests & Specialties: General surgery, peritoneal mesothelioma, surgical oncology, endocrine surgery, neoplasm seeding, skin cancer, colectomy, endocrine disorders, gastrointestinal surgery, hepatobiliary and pancreatic surgery.
Certifications, Awards & Accolades: American Board of Surgery Certification, ACS Fellow, CMS Stage 1, member of the American Association of Endocrine Surgeons
Education & Experience:
- Medical Degree from Columbia University College of Physicians & Surgeons
- Residency for General Surgery at New York Presbyterian Hospital
- Fellowship at New York Presbyterian Hospital
Increased tumor establishment and growth after open versus laparoscopic surgery in mice may be related to differences in postoperative T cell function. Surgical Endoscopy. March 1999;13(3):233-5.
Increased Tumor Establishment and Growth After Laparotomy vs Laparoscopy in a Murine Model. Archives of Surgery. June 1995;130(6):649-653. doi: 10.1001/archsurg.1995.01430060087016
Postoperative immune function varies inversely with the degree of surgical trauma in a murine model. Surgical Endoscopy. May1997;11(5):427-30.
Quantitative X-ray computed tomography peritoneography in malignant peritoneal mesothelioma patients receiving intraperitoneal chemotherapy. Annals of Surgical Oncology. December 2013(20)suppl 3:553–559. doi: 10.1245/s10434-013-2976-8
Neoadjuvant chemotherapy and radiation for patients with locally unresectable pancreatic adenocarcinoma: feasibility, efficacy, and survival. Journal of Gastrointestinal Surgery. January 2008;12(1):91-100. doi: 10.1007/s11605-007-0296-7
The effect of peritoneal air exposure on postoperative tumor growth. Surgical Endoscopy. April 1998;12(4):348-50.
- Mesothelioma Doctors
- Cancer Centers
- Treatment Near You
- Experimental Treatments
- Alternative Treatments
- Clinical Trials
- Caregiver Resources
- Treatment Costs